Related Experiment Video
Updated: Mar 18, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Therapy for Cessation of Smoking.
D Bhattacharyya1, S P Rai2, L S Neog3
1Senior Advisor (Medicine & Respiratory Medicine) Army Hospital (Research & Referral), Delhi Cantt - 110 010.
Physician counseling and medications like nicotine replacement therapies, bupropion, and varenicline significantly increase smoking cessation rates. Comprehensive support is crucial for a tobacco-free future.
Area of Science:
- Public Health
- Addiction Medicine
- Pharmacology
Background:
- Tobacco dependence is a widespread chronic relapsing medical illness affecting over 1.1 billion people globally.
- India has a particularly high rate of tobacco consumption.
- Smoking cessation is a major public health challenge.
Purpose of the Study:
- To review current and potential interventions for smoking cessation.
- To highlight the effectiveness of physician counseling and pharmacotherapy.
- To emphasize the importance of societal support in achieving tobacco-free goals.
Main Methods:
- Review of existing literature on smoking cessation strategies.
- Analysis of the efficacy of various pharmacological and non-pharmacological interventions.
- Discussion of challenges in smoking cessation, such as withdrawal symptoms.
Main Results:
- Three-minute physician counseling doubles cessation rates compared to no intervention.
- Nicotine replacement products, bupropion, and varenicline, combined with counseling, double one-year cessation rates.
- Newer drugs like buspirone and naltrexone show potential for future use.
Conclusions:
- Combining physician counseling with pharmacotherapy is highly effective for smoking cessation.
- Addressing withdrawal symptoms and providing continuous support are key to success.
- A multi-faceted approach involving healthcare providers, family, and society is essential for a tobacco-free world.
More Related Videos
14:21Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
CNS Depressants: Alcohol and Nicotine
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
COPD: Management Using Bronchodilators and Corticosteroids
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...